Total Payments
$17,405
2024 Payments
$2,813
Companies
50
Transactions
1,210
Medicare Patients
7,830
Medicare Billing
$813,662
Payment Breakdown by Category
Food & Beverage$17,275 (99.3%)
Education$129.97 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,275 | 1,205 | 99.3% |
| Education | $129.97 | 5 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,848 | 134 | $0 (2024) |
| ABBVIE INC. | $1,757 | 105 | $0 (2024) |
| Novo Nordisk Inc | $1,698 | 115 | $0 (2024) |
| PFIZER INC. | $1,378 | 121 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,298 | 78 | $0 (2024) |
| Allergan, Inc. | $1,069 | 103 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $968.00 | 62 | $0 (2024) |
| Merck Sharp & Dohme LLC | $704.60 | 54 | $0 (2024) |
| Amgen Inc. | $676.67 | 45 | $0 (2024) |
| Lilly USA, LLC | $661.83 | 55 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,813 | 169 | ABBVIE INC. ($699.35) |
| 2023 | $2,198 | 136 | AbbVie Inc. ($427.61) |
| 2022 | $1,588 | 107 | ABBVIE INC. ($370.17) |
| 2021 | $1,974 | 129 | AbbVie Inc. ($259.62) |
| 2020 | $2,013 | 140 | Allergan, Inc. ($309.71) |
| 2019 | $2,037 | 164 | Allergan Inc. ($240.32) |
| 2018 | $2,603 | 198 | Allergan Inc. ($363.05) |
| 2017 | $2,179 | 167 | Novo Nordisk Inc ($206.06) |
All Payment Transactions
1,210 individual payment records from CMS Open Payments — Page 1 of 49
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: DERMATOLOGY | ||||||
| 11/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: Obesity | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: DIABETES | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: PSYCHIATRY | ||||||
| 11/08/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $6.65 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: PSYCHIATRY | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Obesity | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.69 | General |
| 10/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Diabetes Care | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: VACCINES | ||||||
| 10/21/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.51 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,615 | 2,759 | $382,832 | $187,500 |
| 2022 | 23 | 1,816 | 3,127 | $424,334 | $209,877 |
| 2021 | 27 | 2,080 | 3,387 | $443,364 | $222,415 |
| 2020 | 26 | 2,319 | 3,538 | $429,145 | $193,870 |
Total Patients
7,830
Total Services
12,811
Medicare Billing
$813,662
Procedure Codes
98
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 338 | 1,094 | $213,330 | $85,879 | 40.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 289 | 289 | $43,350 | $34,759 | 80.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 176 | 177 | $13,245 | $12,711 | 96.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 62 | 158 | $21,488 | $9,445 | 44.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 38 | 43 | $18,920 | $8,556 | 45.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 21 | 21 | $8,190 | $5,936 | 72.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 58 | 154 | $11,550 | $5,700 | 49.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 186 | 187 | $5,610 | $5,421 | 96.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 33 | 35 | $9,030 | $3,491 | 38.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 41 | 50 | $6,750 | $3,067 | 45.4% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2023 | 14 | 24 | $2,760 | $1,876 | 68.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 12 | $3,780 | $1,818 | 48.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 29 | $3,915 | $1,781 | 45.5% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 21 | 57 | $3,192 | $1,659 | 52.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 95 | 165 | $7,425 | $1,426 | 19.2% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 88 | 129 | $5,160 | $996.98 | 19.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 19 | 21 | $1,407 | $732.64 | 52.1% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 20 | 20 | $900.00 | $692.40 | 76.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 14 | $1,120 | $573.32 | 51.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 19 | 19 | $665.00 | $550.81 | 82.8% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 13 | 13 | $325.00 | $265.20 | 81.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 35 | 48 | $720.00 | $163.68 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 371 | 1,230 | $239,850 | $100,108 | 41.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 294 | 294 | $44,100 | $36,413 | 82.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 237 | 245 | $17,106 | $16,549 | 96.7% |
About Dr. Gregory Brian, M.D
Dr. Gregory Brian, M.D is a Family Medicine healthcare provider based in Alexandria, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1184616252.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Brian, M.D has received a total of $17,405 in payments from pharmaceutical and medical device companies, with $2,813 received in 2024. These payments were reported across 1,210 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($17,275).
As a Medicare-enrolled provider, Brian has provided services to 7,830 Medicare beneficiaries, totaling 12,811 services with total Medicare billing of $813,662. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Alexandria, LA
- Active Since 08/16/2005
- Last Updated 03/26/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1184616252
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,217
- VRAYLAR (Drug) $1,014
- FARXIGA (Drug) $962.93
- QULIPTA (Drug) $750.11
- ELIQUIS (Drug) $632.84
- Ozempic (Drug) $619.93
- JARDIANCE (Drug) $589.30
- UBRELVY (Drug) $537.03
- Livalo (Drug) $373.23
- TRINTELLIX (Drug) $356.75
- XARELTO (Drug) $344.71
- JANUVIA (Drug) $330.50
- REXULTI (Drug) $327.55
- TRULICITY (Drug) $325.68
- LINZESS (Drug) $287.74
- XIFAXAN (Drug) $276.70
- Victoza (Drug) $266.58
- ANORO (Drug) $258.10
- Vascepa (Drug) $254.88
- NEXLETOL (Drug) $246.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Alexandria
Gregory Bevels, Md, MD
Family Medicine — Payments: $57,537
Family Medicine $57,537
Dr. Kenneth Brown, M.d, M.D
Family Medicine — Payments: $19,993
Family Medicine $19,993
Dr. Jonathan Hunter, M.d, M.D
Family Medicine — Payments: $16,967
Family Medicine $16,967
Vivian Lugo-Eschenwald, Md, MD
Family Medicine — Payments: $11,939
Family Medicine $11,939
Dr. Margo Thomas, M.d, M.D
Family Medicine — Payments: $10,616
Family Medicine $10,616
Michelle Murray, M.d, M.D
Family Medicine — Payments: $8,423
Family Medicine $8,423